Sponsor pipeline

Oliver Blanchard clinical trial pipeline

Get alerts when Oliver Blanchard's trials change

1 active trials 1 recruiting 1 disease areas 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT06249867 A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients… Amyotrophic Lateral Sclerosis Recruiting 2026-10-09

Disease areas by active trials

ALS (1)

Get alerts when Oliver Blanchard's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free